The Discounted Cash Flow (DCF) valuation of Gilead Sciences Inc (GILD) is 33.75 USD. With the latest stock price at 101.43 USD, the upside of Gilead Sciences Inc based on DCF is -66.7%.
Based on the latest price of 101.43 USD and our DCF valuation, Gilead Sciences Inc (GILD) is a sell. selling Gilead stocks now will result in a potential gain of 66.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.5% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 18.40 - 82.16 | 33.75 |
| Upside | -81.9% - -19.0% | -66.7% |